Company / Return on Equity (ROE)
Edwards Lifesciences Return on Equity (ROE) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
10.4%
FY2025
5-year range
10.4% / 41.8%
FY2021-FY2025
Trend
-75.1%
vs FY2024
Sector context
#50 of 148
Health Care
What the data says
At 10.4%, Edwards Lifesciences's return on equity (roe) ranks #50 of 148 in the Health Care sector. Return on Equity (ROE) has fluctuated over the past 5 years, ranging from 10.4% in FY2025 to 41.8% in FY2024.
Based on SEC 10-K filings.
10.4% in FY2025 with a 3-year CAGR of -15.8%.
Declined from 22.6% to 10.4% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -15.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#50 of 148 in Health CareTop 34% of 148This company 10.4% Sector average -3.2%
▼
+428.7% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 75.1% year-over-year.
- Currently 13.5pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 10.4% | -75.1% |
| FY2024 | 41.8% | +84.7% |
| FY2023 | 22.6% | -13.8% |
| FY2022 | 26.2% | +1.7% |
| FY2021 | 25.8% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026